Items tagged with Advocacy

Open letters to Johnson & Johnson requesting equitable access to bedaquiline (post with simple image)

Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.

Johnson & Johnson confirms intent not to enforce patents for SIRTURO® (bedaquiline) for the treatment of multidrug-resistant TB in 134 low- and middle-income countries (post with simple image)

The decision is intended to assure current and future generic manufacturers that they may manufacture and sell generic versions of SIRTURO® without a concern that the Company will enforce its bedaquiline patents, provided the generic versions of SIRTURO® are of good quality, medically acceptable, and are used only in the 134 low- and middle-income countries.

Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest (post with simple image)

Unitaid calls on Johnson & Johnson to drop secondary patents for the drug-resistant TB medicine bedaquiline, and to make negotiated rates with the Stop TB Partnership’s Global Drug Facility available to all countries, regardless of how they purchase drugs.

UN General Assembly formally adopts Resolution on Political Declaration on TB (post with simple image)

The United Nations General Assembly has formally adopted by consensus the Political Declaration of the High-Level Meeting on the Fight against Tuberculosis.

Eradicating TB: time to make this age-old dream a reality (post with simple image)

A call to action ahead of the Union Conference urges France to confirm the commitments made in the UN Political Declaration on TB and to translate it into concrete measures.

Global TB report 2023: TB response recovering from pandemic but accelerated efforts needed to meet new targets (post with simple image)

Despite significant recovery in 2022, progress is insufficient to meet global TB targets set in 2018 with disruptions caused by the pandemic and ongoing conflicts being major contributing factors.

Activism delivers unprecedented victories in TB testing and treatment access (post with simple image)

Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

Call for experts: WHO Civil Society Task Force on TB (2024-2025 mandate) (post with simple image)

The World Health Organization launches a call for experts to serve as members of the Civil Society Task Force on TB. Deadline to apply: 23 November 2023.

Call for nominations: Stop TB Partnership Community Award 2023 (post with simple image)

The Stop TB Partnership launches a call for nominations for the Community Award 2023 under the theme - Serving the most vulnerable: Increasing access to TB services for key and vulnerable populations. Deadline for nominations: 1 December 2023.

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB (post with simple image)

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Page 120 of 121 · Total posts: 0

←First 119 120 121 Last→